Introduction: Historically, therapeutic avenues for patients with clinical stage II seminoma germ cell tumors (SGCT) were confined to radiotherapy and chemotherapy. While survival rates with these modalities are commendable, both entail substantial long-term morbidities. Furthermore, this youthful patient cohort exhibits elevated rates of secondary malignancies, surfacing decades post-successful primary cancer treatment (1). Recently, retroperitoneal lymph node dissection (RPLND) has emerged as a primary treatment consideration for individuals with low-volume metastatic seminoma (2-4). However, there is a dearth of video documentation illustrating the robotic assisted (RA) bilateral approach (5- 7).
Methods: We present the case of a 24-year-old male who underwent prior left orchiectomy for seminoma (pT1b). Despite negative serum tumor markers, a 1.7 x 1.4cm lymph node enlargement was identified in the aortic bifurcation after 4 months, classifying the patient as stage IIA per the IGCCCG risk classification. Subsequently, a RA bilateral template RPLND was performed due to the patient's refusal of chemotherapy, citing concerns about offspring.
Results: The surgery was performed, incorporating nerve sparing techniques, lasting 4h13minutes, an estimated bleeding rate of 400ml, without intraoperative complications. The patient was discharged within 24 hours of the procedure, following a prescribed low-fat diet.
Conclusion: The patient experienced postoperative well-being, painlessness, and resumed work three weeks post-procedure. Preserved ejaculation was noted, and adjuvant therapy was performed with 2 cycles of EP due to the anatomopathological result. The feasibility of robotic primary RPLND for SGCT was demonstrated, showing reduced postoperative pain and early hospital discharge. Further studies are necessary to validate our findings regarding oncological, safety, and functional outcomes.
简介一直以来,临床 II 期精原细胞瘤(SGCT)患者的治疗手段仅限于放疗和化疗。虽然这些方法的存活率值得称赞,但都会带来大量的长期病痛。此外,这一年轻患者群体的继发性恶性肿瘤发生率较高,在原发性癌症治疗成功后数十年才出现(1)。最近,腹膜后淋巴结清扫术(RPLND)已成为低体积转移性精原细胞瘤患者的主要治疗方法(2-4)。然而,机器人辅助(RA)双侧方法的视频文件却很少(5- 7):我们介绍了一例 24 岁男性的病例,他曾因精索瘤(pT1b)接受过左侧睾丸切除术。尽管血清肿瘤标志物呈阴性,但 4 个月后在主动脉分叉处发现了 1.7 x 1.4 厘米的淋巴结肿大,根据 IGCCCG 风险分类将患者归为 IIA 期。随后,由于患者以担心后代为由拒绝化疗,于是进行了 RA 双侧模板 RPLND:手术采用了神经保护技术,历时 4 小时 13 分钟,出血量估计为 400 毫升,术中无并发症。患者在术后 24 小时内出院,遵医嘱进食低脂饮食:结论:患者术后感觉良好,无痛苦,术后三周即可恢复工作。患者保留了射精功能,由于解剖病理结果,患者接受了两个周期的EP辅助治疗。机器人原发性RPLND治疗SGCT的可行性得到了证实,术后疼痛减轻,出院时间提前。有必要进行进一步研究,以验证我们在肿瘤学、安全性和功能性结果方面的发现。
{"title":"Robot-assisted retroperitoneal lymph node dissection as primary treatment for stage II seminoma germ cell tumor.","authors":"Stefano Cogo Badan, Willy Baccaglini, Arie Carneiro, Gustavo Caserta Lemos","doi":"10.1590/S1677-5538.IBJU.2023.0389","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0389","url":null,"abstract":"<p><strong>Introduction: </strong>Historically, therapeutic avenues for patients with clinical stage II seminoma germ cell tumors (SGCT) were confined to radiotherapy and chemotherapy. While survival rates with these modalities are commendable, both entail substantial long-term morbidities. Furthermore, this youthful patient cohort exhibits elevated rates of secondary malignancies, surfacing decades post-successful primary cancer treatment (1). Recently, retroperitoneal lymph node dissection (RPLND) has emerged as a primary treatment consideration for individuals with low-volume metastatic seminoma (2-4). However, there is a dearth of video documentation illustrating the robotic assisted (RA) bilateral approach (5- 7).</p><p><strong>Methods: </strong>We present the case of a 24-year-old male who underwent prior left orchiectomy for seminoma (pT1b). Despite negative serum tumor markers, a 1.7 x 1.4cm lymph node enlargement was identified in the aortic bifurcation after 4 months, classifying the patient as stage IIA per the IGCCCG risk classification. Subsequently, a RA bilateral template RPLND was performed due to the patient's refusal of chemotherapy, citing concerns about offspring.</p><p><strong>Results: </strong>The surgery was performed, incorporating nerve sparing techniques, lasting 4h13minutes, an estimated bleeding rate of 400ml, without intraoperative complications. The patient was discharged within 24 hours of the procedure, following a prescribed low-fat diet.</p><p><strong>Conclusion: </strong>The patient experienced postoperative well-being, painlessness, and resumed work three weeks post-procedure. Preserved ejaculation was noted, and adjuvant therapy was performed with 2 cycles of EP due to the anatomopathological result. The feasibility of robotic primary RPLND for SGCT was demonstrated, showing reduced postoperative pain and early hospital discharge. Further studies are necessary to validate our findings regarding oncological, safety, and functional outcomes.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"225-226"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1590/S1677-5538.IBJU.2024.9905
Cristiano M Gomes, Giovanni Marchini, Jose de Bessa, Gustavo Carvalhal, Marina P R Caldeira, Paulo Hilario Saldiva, Jose Eduardo Krieger, Fabiana Agena, Sabrina Reis, Candice Paschoal, Milena Froes, Miguel Srougi, William C Nahas, Luciano A Favorito
Objective: The objective of this narrative review is to discuss the current state of research funding in Brazil.
Materials and methods: This study is based on the most recent edition of the course Funding for Research and Innovation in the University of Sao Paulo School of Medicine which was a three-day course with 12 hours of instruction. The course brought together leading experts in the field to comprehensively discuss the current state of research funding in Brazil. Each speaker provided a presentation on a specific topic related to research funding. After the workshop, speakers assembled relevant topics in this manuscript.
Results: collaborative research is critical for securing research funding. It optimizes proposal competitiveness, amplifies societal impact, and manages risks effectively. As such, fostering and supporting these collaborations is paramount for both researchers and funding agencies. To maintain the highest integrity in research, investigators involved in these collaborations must disclose any relationships that could potentially influence the outcomes or interpretation of their projects.
Conclusions: In Brazil, the mainstay of research funding stems from public entities, with agencies such as CNPq, CAPES, and state bodies like FAPESP, FAPERJ, FAPEMIG and others at the forefront. Concurrently, industry funding offers viable pathways, especially through industry-sponsored studies, investigator-led projects, and collaborative initiatives. The Brazilian funding landscape is further enriched by innovative platforms, including crowdfunding and the contributions of institutions like the Serrapilheira Institute. Internationally, esteemed organizations such as the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation stand out as potential funders.
{"title":"The landscape of biomedical research funding in Brazil: a current overview.","authors":"Cristiano M Gomes, Giovanni Marchini, Jose de Bessa, Gustavo Carvalhal, Marina P R Caldeira, Paulo Hilario Saldiva, Jose Eduardo Krieger, Fabiana Agena, Sabrina Reis, Candice Paschoal, Milena Froes, Miguel Srougi, William C Nahas, Luciano A Favorito","doi":"10.1590/S1677-5538.IBJU.2024.9905","DOIUrl":"10.1590/S1677-5538.IBJU.2024.9905","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this narrative review is to discuss the current state of research funding in Brazil.</p><p><strong>Materials and methods: </strong>This study is based on the most recent edition of the course Funding for Research and Innovation in the University of Sao Paulo School of Medicine which was a three-day course with 12 hours of instruction. The course brought together leading experts in the field to comprehensively discuss the current state of research funding in Brazil. Each speaker provided a presentation on a specific topic related to research funding. After the workshop, speakers assembled relevant topics in this manuscript.</p><p><strong>Results: </strong>collaborative research is critical for securing research funding. It optimizes proposal competitiveness, amplifies societal impact, and manages risks effectively. As such, fostering and supporting these collaborations is paramount for both researchers and funding agencies. To maintain the highest integrity in research, investigators involved in these collaborations must disclose any relationships that could potentially influence the outcomes or interpretation of their projects.</p><p><strong>Conclusions: </strong>In Brazil, the mainstay of research funding stems from public entities, with agencies such as CNPq, CAPES, and state bodies like FAPESP, FAPERJ, FAPEMIG and others at the forefront. Concurrently, industry funding offers viable pathways, especially through industry-sponsored studies, investigator-led projects, and collaborative initiatives. The Brazilian funding landscape is further enriched by innovative platforms, including crowdfunding and the contributions of institutions like the Serrapilheira Institute. Internationally, esteemed organizations such as the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation stand out as potential funders.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"209-222"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1590/S1677-5538.IBJU.2024.02.01
Luciano A Favorito
{"title":"In this issue we will celebrate 50 years of the International Brazilian Journal of Urology.","authors":"Luciano A Favorito","doi":"10.1590/S1677-5538.IBJU.2024.02.01","DOIUrl":"10.1590/S1677-5538.IBJU.2024.02.01","url":null,"abstract":"","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"115-118"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1590/S1677-5538.IBJU.2023.0570
Antonio Vitor Nascimento Martinelli Braga, Noel Charlles Nunes, Emanoel Nascimento Santos, Maria Luiza Veiga, Ana Aparecida Nascimento Martinelli Braga, Glicia Estevam de Abreu, Jose de Bessa, Luis Henrique Braga, Andrew J Kirsch, Ubirajara Barroso
Purpouse: One of the many artificial intelligence based tools that has gained popularity is the Chat-Generative Pre-Trained Transformer (ChatGPT). Due to its popularity, incorrect information provided by ChatGPT will have an impact on patient misinformation. Furthermore, it may cause misconduct as ChatGPT can mislead physicians on the decision-making pathway. Therefore, the aim of this study is to evaluate the accuracy and reproducibility of ChatGPT answers regarding urological diagnoses.
Materials and methods: ChatGPT 3.5 version was used. The questions asked for the program involved Primary Megaureter (pMU), Enuresis and Vesicoureteral Reflux (VUR). There were three queries for each topic. The queries were inserted twice, and both responses were recorded to examine the reproducibility of ChatGPT's answers. Afterwards, both answers were combined. Finally, those rwere evaluated qualitatively by a board of three specialists. A descriptive analysis was performed.
Results and conclusion: ChatGPT simulated general knowledge on the researched topics. Regarding Enuresis, the provided definition was partially correct, as the generic response allowed for misinterpretation. For VUR, the response was considered appropriate. For pMU it was partially correct, lacking essential aspects of its definition such as the diameter of the dilatation of the ureter. Unnecessary exams were suggested, for Enuresis and pMU. Regarding the treatment of the conditions mentioned, it specified treatments for Enuresis that are ineffective, such as bladder training. Therefore, ChatGPT responses present a combination of accurate information, but also incomplete, ambiguous and, occasionally, misleading details.
{"title":"Use of ChatGPT in Urology and its Relevance in Clinical Practice: Is it useful?","authors":"Antonio Vitor Nascimento Martinelli Braga, Noel Charlles Nunes, Emanoel Nascimento Santos, Maria Luiza Veiga, Ana Aparecida Nascimento Martinelli Braga, Glicia Estevam de Abreu, Jose de Bessa, Luis Henrique Braga, Andrew J Kirsch, Ubirajara Barroso","doi":"10.1590/S1677-5538.IBJU.2023.0570","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0570","url":null,"abstract":"<p><strong>Purpouse: </strong>One of the many artificial intelligence based tools that has gained popularity is the Chat-Generative Pre-Trained Transformer (ChatGPT). Due to its popularity, incorrect information provided by ChatGPT will have an impact on patient misinformation. Furthermore, it may cause misconduct as ChatGPT can mislead physicians on the decision-making pathway. Therefore, the aim of this study is to evaluate the accuracy and reproducibility of ChatGPT answers regarding urological diagnoses.</p><p><strong>Materials and methods: </strong>ChatGPT 3.5 version was used. The questions asked for the program involved Primary Megaureter (pMU), Enuresis and Vesicoureteral Reflux (VUR). There were three queries for each topic. The queries were inserted twice, and both responses were recorded to examine the reproducibility of ChatGPT's answers. Afterwards, both answers were combined. Finally, those rwere evaluated qualitatively by a board of three specialists. A descriptive analysis was performed.</p><p><strong>Results and conclusion: </strong>ChatGPT simulated general knowledge on the researched topics. Regarding Enuresis, the provided definition was partially correct, as the generic response allowed for misinterpretation. For VUR, the response was considered appropriate. For pMU it was partially correct, lacking essential aspects of its definition such as the diameter of the dilatation of the ureter. Unnecessary exams were suggested, for Enuresis and pMU. Regarding the treatment of the conditions mentioned, it specified treatments for Enuresis that are ineffective, such as bladder training. Therefore, ChatGPT responses present a combination of accurate information, but also incomplete, ambiguous and, occasionally, misleading details.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"192-198"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1590/S1677-5538.IBJU.2023.0402
Joshua White, Katherine Campbell, Nicholas Deebel, Akhil Muthigi, Francesco Costantini Mesquita, Lucas Campos, Christabel Egemba, Maria Camila Suarez Albaraez, Braian Ledesma, Jesse Ory, Ranjith Ramasamy
Objective: This retrospective study aimed to evaluate the effectiveness of low-dose prednisone as a rescue therapy for patients with deteriorating semen parameters following vasovasostomy.
Materials and methods: Electronic medical records were queried at the University of Miami with documented CPT code 55400 (Bilateral Vasovasostomy) between January 2016 and April 2023. Records were then reviewed to identify patients who demonstrated ≥50% decrease in semen parameters, specifically sperm concentration, motility and total motile sperm count. Patients who were treated with 6 weeks of low-dose prednisone were identified, and baseline semen parameters and subsequent changes after prednisone therapy were assessed. A Mann-Whitney U Test was used to compare semen parameter changes before and after prednisone. Adverse effects associated with prednisone were monitored.
Results: A total of 8 patients were identified with deteriorating semen parameters who were treated with 6 weeks of low-dose prednisone. Following prednisone therapy, all patients demonstrated improvements in total motile sperm count (TMSC), with a median improvement of 6 million. The median relative improvement in TMSC was 433%. Sperm concentration and motility also improved compared to post-operative baseline. No adverse effects were reported during the treatment period.
Conclusions: Low-dose prednisone therapy appears to be a safe and effective intervention for managing deteriorating semen parameters following VV. The observed improvements in TMSC suggest the potential of prednisone to rescue patients with delayed failure after VV. Further research with larger sample sizes is warranted to confirm the safety and efficacy of low-dose prednisone as a rescue therapy in this specific patient population. Optimizing VV outcomes is crucial in male infertility, and further exploration of steroid therapy and innovative biotechnologies is warranted.
{"title":"Low-dose prednisone is an effective rescue for deteriorating semen parameters following vasovasostomy.","authors":"Joshua White, Katherine Campbell, Nicholas Deebel, Akhil Muthigi, Francesco Costantini Mesquita, Lucas Campos, Christabel Egemba, Maria Camila Suarez Albaraez, Braian Ledesma, Jesse Ory, Ranjith Ramasamy","doi":"10.1590/S1677-5538.IBJU.2023.0402","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0402","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective study aimed to evaluate the effectiveness of low-dose prednisone as a rescue therapy for patients with deteriorating semen parameters following vasovasostomy.</p><p><strong>Materials and methods: </strong>Electronic medical records were queried at the University of Miami with documented CPT code 55400 (Bilateral Vasovasostomy) between January 2016 and April 2023. Records were then reviewed to identify patients who demonstrated ≥50% decrease in semen parameters, specifically sperm concentration, motility and total motile sperm count. Patients who were treated with 6 weeks of low-dose prednisone were identified, and baseline semen parameters and subsequent changes after prednisone therapy were assessed. A Mann-Whitney U Test was used to compare semen parameter changes before and after prednisone. Adverse effects associated with prednisone were monitored.</p><p><strong>Results: </strong>A total of 8 patients were identified with deteriorating semen parameters who were treated with 6 weeks of low-dose prednisone. Following prednisone therapy, all patients demonstrated improvements in total motile sperm count (TMSC), with a median improvement of 6 million. The median relative improvement in TMSC was 433%. Sperm concentration and motility also improved compared to post-operative baseline. No adverse effects were reported during the treatment period.</p><p><strong>Conclusions: </strong>Low-dose prednisone therapy appears to be a safe and effective intervention for managing deteriorating semen parameters following VV. The observed improvements in TMSC suggest the potential of prednisone to rescue patients with delayed failure after VV. Further research with larger sample sizes is warranted to confirm the safety and efficacy of low-dose prednisone as a rescue therapy in this specific patient population. Optimizing VV outcomes is crucial in male infertility, and further exploration of steroid therapy and innovative biotechnologies is warranted.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 1","pages":"58-64"},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1590/S1677-5538.IBJU.2024.9902
Faruk Hadziselimovic
In 2007 the Nordic group came to the following unanimous conclusions: In general, hormonal treatment is not recommended, considering the poor immediate results and the possible long-term adverse effects on spermatogenesis. Thus, surgery is to be preferred. However, defective mini puberty inducing insufficient gonadotropin secretion is one of the most common causes of nonobstructive azoospermia in men suffering from congenital isolated unilateral or bilateral cryptorchidism. The extent of alteration in the unilateral undescended testis correlate with the contralateral descended testis, indicating that unilateral cryptorchidism is a bilateral disease. Idiopathic central hypogonadism explains the phenomenon of defective mini puberty in otherwise healthy cryptorchid boys. We therefore recommend hormonal treatment for cryptorchid boys with defective mini puberty. Gonadotropin releasing hormone agonist (GnRHa) treatment following surgery to correct cryptorchidism restores mini puberty via endocrinological and transcriptional effects and prevents adult infertility in most cases. Several genes are important for central hypogonadotropic hypogonadism in mammals, including many that are transcribed in both the brain and testis. At the molecular level, there is no convincing evidence that heat shock is responsible for the observed pathological testicular changes. Thus, impaired transformation of gonocytes is not the result of temperature stress but rather a hormonal imbalance. Cryptorchidism should therefore be considered a serious andrological problem that cannot be successfully treated by early orchidopexy alone.
{"title":"Advocating hormonal treatment to prevent adult in-fertility in patients diagnosed with congenital un-descended testes.","authors":"Faruk Hadziselimovic","doi":"10.1590/S1677-5538.IBJU.2024.9902","DOIUrl":"10.1590/S1677-5538.IBJU.2024.9902","url":null,"abstract":"<p><p>In 2007 the Nordic group came to the following unanimous conclusions: In general, hormonal treatment is not recommended, considering the poor immediate results and the possible long-term adverse effects on spermatogenesis. Thus, surgery is to be preferred. However, defective mini puberty inducing insufficient gonadotropin secretion is one of the most common causes of nonobstructive azoospermia in men suffering from congenital isolated unilateral or bilateral cryptorchidism. The extent of alteration in the unilateral undescended testis correlate with the contralateral descended testis, indicating that unilateral cryptorchidism is a bilateral disease. Idiopathic central hypogonadism explains the phenomenon of defective mini puberty in otherwise healthy cryptorchid boys. We therefore recommend hormonal treatment for cryptorchid boys with defective mini puberty. Gonadotropin releasing hormone agonist (GnRHa) treatment following surgery to correct cryptorchidism restores mini puberty via endocrinological and transcriptional effects and prevents adult infertility in most cases. Several genes are important for central hypogonadotropic hypogonadism in mammals, including many that are transcribed in both the brain and testis. At the molecular level, there is no convincing evidence that heat shock is responsible for the observed pathological testicular changes. Thus, impaired transformation of gonocytes is not the result of temperature stress but rather a hormonal imbalance. Cryptorchidism should therefore be considered a serious andrological problem that cannot be successfully treated by early orchidopexy alone.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 1","pages":"20-27"},"PeriodicalIF":3.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1590/S1677-5538.IBJU.2024.01.01
Luciano A Favorito
{"title":"Infertility is the hot topic in the 1st number of International Brazilian Journal of Urology in 2024.","authors":"Luciano A Favorito","doi":"10.1590/S1677-5538.IBJU.2024.01.01","DOIUrl":"10.1590/S1677-5538.IBJU.2024.01.01","url":null,"abstract":"","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 1","pages":"1-3"},"PeriodicalIF":3.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1590/S1677-5538.IBJU.2024.9903
Sandro C Esteves
{"title":"The Impact of Male Infertility Research on the International Brazilian Journal of Urology: An Associate Editor's Overview.","authors":"Sandro C Esteves","doi":"10.1590/S1677-5538.IBJU.2024.9903","DOIUrl":"10.1590/S1677-5538.IBJU.2024.9903","url":null,"abstract":"","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 1","pages":"95-99"},"PeriodicalIF":3.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947649/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1590/S1677-5538.IBJU.2024.01.03
Philippe E Spiess
{"title":"Selection of best videos of the year for 2023.","authors":"Philippe E Spiess","doi":"10.1590/S1677-5538.IBJU.2024.01.03","DOIUrl":"https://doi.org/10.1590/S1677-5538.IBJU.2024.01.03","url":null,"abstract":"","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 1","pages":"5-6"},"PeriodicalIF":3.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}